Last quarter (Q ), Clovis Oncology's total revenue was $30.66M, a decrease of -19.13% from the same quarter last year. In Q, Clovis Oncology's net income was $-56.01M. See Clovis Oncology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 133.02M	$ 148.76M	$ 164.52M	$ 143.01M	$ 95.39M	$ 55.51M
Cost of Revenue	$ 21.09M	$ -33.45M	$ 41.30M	$ 34.69M	$ 22.07M	$ 11.74M
Gross Profit	$ 96.06M	$ 104.45M	$ 123.22M	$ 108.32M	$ 73.31M	$ 43.77M
Operating Expense	$ 302.74M	$ 330.22M	$ 425.40M	$ 485.07M	$ 407.13M	$ 281.40M
Operating Income	$ -206.69M	$ -225.77M	$ -302.19M	$ -376.75M	$ -333.81M	$ -237.63M
Net Non Operating Interest Income Expense	$ -37.15M	$ -34.10M	$ -30.51M	$ -19.41M	$ -13.18M	$ -10.43M
Other Income Expense	$ -6.79M	$ -444.00K	$ -37.06M	$ -2.48M	$ -20.40M	$ -101.92M
Pretax Income	$ -252.31M	$ -264.93M	$ -369.76M	$ -398.63M	$ -367.40M	$ -349.98M
Tax Provision	$ -405.00K	$ -404.00K	$ -547.00K	$ 1.80M	$ 608.00K	$ -3.58M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -251.91M	$ -264.52M	$ -369.21M	$ -400.42M	$ -368.01M	$ -346.40M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 323.83M	$ 296.77M	$ 466.71M	$ 519.75M	$ 429.20M	$ 293.14M
Net Income From Continuing And Discontinued Operation	$ -251.91M	$ -264.52M	$ -369.21M	$ -400.42M	$ -368.01M	$ -346.40M
Normalized Income	$ -188.94M	-	$ -365.87M	$ -393.99M	$ -347.33M	$ -241.89M
Interest Expense	$ 25.61M	-	$ 23.49M	$ 16.55M	$ 11.01M	$ 9.15M
EBIT	$ -216.84M	$ -230.82M	$ -346.27M	$ -382.08M	$ -356.40M	$ -340.83M
EBITDA	$ -208.56M	$ -219.90M	$ -338.07M	$ -374.31M	$ -351.80M	$ -338.32M

Currency in USD

Clovis Oncology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing